98%
921
2 minutes
20
Objective: To construct a prediction model for the risk of depression in the obese population, aiming to facilitate the early identification of high-risk individuals and guide personalized preventive interventions.
Methods: This study was based on the data from the China Health and Retirement Longitudinal Study (CHARLS 2015), the Center for Epidemiologic Studies Depression Scale-10 (CES-D10) to assess the depression of obese patients, Lasso regression and multivariable logistic regression were used to select predictors, the construction of a nomogram model, and the use of the random splitting method divided into a training set ( = 974) and a validation set ( = 418) by the 7:3 method, and the model was evaluated by the ROC curves and the AUC, the H-L goodness-of-fit test, the calibration graphs, and the clinical decision-making curve to assess the model.
Results: A total of 1,392 obese patients were finally included, with a prevalence of depression of 32.68%. Age, respiratory function, renal disease, digestive disease, grip strength, rheumatism and arthritis, and sleep duration were selected to construct the predictive nomogram model of depression risk in obese patients, and the AUCs of the training set and validation set were 0.715 (95% CI = 0.681-0.749) and 0.716 (95% CI = 0.665-0.767). This suggests that the model has moderate discriminatory power. Respectively, the H-L test was statistically insignificant ( > 0.05, H-L test; > 0.05). Goodness of fit, calibration curves showed significant agreement between the model and actual observations, and clinical decision curves indicated good model calibration and net benefit.
Conclusion: The model constructed in this study has good efficacy in predicting the occurrence of depression in the obese population and can be used for the early identification of high-risk groups and the adoption of targeted preventive measures to reduce the risk of depression.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12116313 | PMC |
http://dx.doi.org/10.3389/fpubh.2025.1574386 | DOI Listing |
Medicine (Baltimore)
September 2025
Department of Sociology, Social Work and Public Health, Faculty of Labour Sciences, University of Huelva, Huelva, Spain.
Cardiac rehabilitation programs (CRPs) are multifactorial interventions defined by the World Health Organization as essential strategies to improve patients' health-related quality of life (HRQoL) by enhancing their physical, psychological, social, and occupational well-being. These programs are a cornerstone in the comprehensive treatment of heart disease, facilitating the recovery of functional capacity and reintegration into the workforce through a multidisciplinary approach. The objective of this study was to assess the efficacy of CRPs in enhancing functional capacity (cardiac and psychological) and HRQoL in workers with ischemic heart disease.
View Article and Find Full Text PDFFront Pharmacol
August 2025
Luzhou Key Laboratory of Traditional Chinese Medicine for Chronic Diseases Jointly Built by Sichuan and Chongqing, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, Sichuan, China.
Introduction: Depression and anxiety are prevalent comorbidities in individuals with chronic diseases, significantly impairing their quality of life and complicating disease management. Curcumin, derived from turmeric (Curcuma longa), has garnered attention for its potential therapeutic benefits in alleviating symptoms of depression and anxiety. However, its specific effects on depressive or anxiety symptoms associated with chronic diseases (DACD) remain unclear.
View Article and Find Full Text PDFAnn Pediatr Endocrinol Metab
August 2025
Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea.
Ever since its discovery, glucagon-like-peptide 1 (GLP-1) and drugs with similar function (collectively GLP-1s) have been used for type 2 diabetes mellitus and have been effective for obesity. Their profound effect on weight loss has resulted in widespread use of these medicines for treating obesity. Extensive studies have shown that GLP-1s decrease body weight, lean mass, and other metabolic phenotypes.
View Article and Find Full Text PDFClin Nutr
May 2025
Department of Epidemiology, Beijing Neurosurgical Institute, Beijing Tiantan Hospital, Capital Medical University, Beijing, China; China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China; Department of Clinical Epidemiol
Background And Aims: Dynapenic abdominal obesity has been shown as a risk factor for adverse outcomes. There is no evidence on the longitudinal association of this condition with different courses of depressive symptoms. This study aimed to investigate the association of dynapenic abdominal obesity status with the risk of distinct trajectories of depressive symptoms.
View Article and Find Full Text PDFEnviron Sci Pollut Res Int
September 2025
Data Forward Analytics, LLC, Principal, Las Cruces, NM, 88011, USA.
Per- and poly-fluoroalkyl substances (PFAS) are fluorinated organic compounds known as forever chemicals that are used in many materials, from cooking appliances to industrial detergents. Given their high chemical stability due to their lipophilic properties and widespread use, PFAS tend to bioaccumulate in the cardiac, hepatic, renal, gastrointestinal, and neural tissues, resulting in a variety of malignant and non-malignant diseases. Depression is a prevalent mental health condition that affects an individual's activities of daily living.
View Article and Find Full Text PDF